These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 34372790)

  • 1. A study to design minimum data set of COVID-19 registry system.
    Zarei J; Badavi M; Karandish M; Haddadzadeh Shoushtari M; Dastoorpoor M; Yousefi F; Raji H; Cheraghi M
    BMC Infect Dis; 2021 Aug; 21(1):773. PubMed ID: 34372790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and development of a web-based registry for Coronavirus (COVID-19) disease.
    Kazemi-Arpanahi H; Moulaei K; Shanbehzadeh M
    Med J Islam Repub Iran; 2020; 34():68. PubMed ID: 32974234
    [No Abstract]   [Full Text] [Related]  

  • 4. Developing a National Minimum Data Set for Kawasaki Disease Registry in Iran.
    Qazizadeh Z; Shahbaznejad L; Navaeifar MR; Rezai MS
    Front Pediatr; 2022; 10():834306. PubMed ID: 35295705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Designing a comprehensive minimum dataset for patients with COVID-19 in Iranian hospital information systems.
    Salmani H; Sharafi S; Almanie A; Niknam F; Naseri Z; Mobarak S; Jelvay S
    Health Inf Manag; 2024 Jan; 53(1):14-19. PubMed ID: 37846732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional COVID-19 registry in Khuzestan, Iran: A study protocol and lessons learned from a pilot implementation.
    Zarei J; Dastoorpoor M; Jamshidnezhad A; Cheraghi M; Sheikhtaheri A
    Inform Med Unlocked; 2021; 23():100520. PubMed ID: 33495736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Designing a minimum data set for the information management system (registry) of spinal canal stenosis: An applied-descriptive study.
    Zarei J; Mohammadi A; Akrami MR; Jeihooni Kalhori A
    Health Sci Rep; 2023 Nov; 6(11):e1671. PubMed ID: 37920660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A minimum data set for traumatic brain injuries in Iran.
    Edalatfar M; Sadeghi-Naini M; Khayat Kashani HR; Movahed M; Sharif-Alhoseini M
    Chin J Traumatol; 2022 Sep; 25(5):283-292. PubMed ID: 34690039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of the Neonatal Abstinence Syndrome Minimum Data Set (NAS-MDS): a systematic review, focus group discussion, and Delphi technique.
    Zakerabasali S; Kadivar M; Safdari R; Niakan Kalhori SR; Mokhtaran M; Karbasi Z; Sayarifard A
    J Matern Fetal Neonatal Med; 2022 Feb; 35(4):617-624. PubMed ID: 33047642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development a national minimum data set for poisoning registry in Iran.
    Banaye Yazdipour A; Sarbaz M; Dadpour B; Moshiri M; Kimiafar K
    Int J Health Plann Manage; 2020 Nov; 35(6):1453-1467. PubMed ID: 32881066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.
    Chaccour C; Ruiz-Castillo P; Richardson MA; Moncunill G; Casellas A; Carmona-Torre F; Giráldez M; Mota JS; Yuste JR; Azanza JR; Fernández M; Reina G; Dobaño C; Brew J; Sadaba B; Hammann F; Rabinovich R
    Trials; 2020 Jun; 21(1):498. PubMed ID: 32513289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developing the minimum data set of the corrosive ingestion registry system in Iran.
    Mahmoudvand Z; Shanbehzadeh M; Shafiee M; Kazemi-Arpanahi H
    BMC Health Serv Res; 2022 Sep; 22(1):1207. PubMed ID: 36167583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Designing Data Elements and Minimum Data Set (MDS) for Creating the Registry of Patients with Gestational Diabetes Mellitus.
    Ahmadi M; Mirbagheri E
    J Med Life; 2019; 12(2):160-167. PubMed ID: 31406518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Pediatric COVID-19 Registry in Kuwait: Methodology and Results of Pilot Phase.
    Qabazard S; Al-Abdulrazzaq D; Al-Kandari H; Ayed M; Alanezi A; Al-Shammari N; Alharbash Z; Al-Khabbaz M; Kalander K; Bin-Hassan S; Alfraij A; Alghounaim M; Alsaeid K; Al-Hashemi H
    Med Princ Pract; 2022; 31(5):471-479. PubMed ID: 35598599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developing A Minimum Data Set for A Rheumatoid Arthritis Registry in Iran.
    Langarizadeh M; Mehrabi N; Azadi T; Mehraeen E; Ahmadzadeh A
    Mediterr J Rheumatol; 2022 Mar; 33(1):55-62. PubMed ID: 35611110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developing a minimum data set for cardiovascular Computerized Physician Order Entry (CPOE) and mapping the data set to FHIR: A multi-method approach.
    Montazeri M; Khajouei R; Mahdavi A; Ahmadian L
    J Med Syst; 2023 Apr; 47(1):47. PubMed ID: 37058148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. THE VALUE OF A REGIONAL 'LIVING' COVID-19 REGISTRY AND THE CHALLENGES OF KEEPING IT ALIVE.
    Hanna J; Chen T; Portales-Castillo C; Said M; Bulnes R; Newhart D; Sienk L; Schantz K; Rozzi K; Alag K; Bress J; Lesho DO E
    Perspect Health Inf Manag; 2021; 18(3):1d. PubMed ID: 34858116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The First Inherited Retinal Disease Registry in Iran: Research Protocol and Results of a Pilot Study.
    Sabbaghi H; Daftarian N; Suri F; Mirrahimi M; Madani S; Sheikhtaheri A; Khorrami F; Saviz P; Zarei Nejad M; Tivay A; Shahriari HA; Maleki A; Ahmadi SS; Sargazi M; Cremers FPM; Najafi M; Vona B; Haaf T; Bahena-Carbajal P; Moghadasi A; Naraghi H; Yaseri M; Kheiri B; Kalantarion M; Sabbaghi E; Salami M; Pazooki L; Zendedel K; Mojarrab S; Ahmadieh H
    Arch Iran Med; 2020 Jul; 23(7):445-454. PubMed ID: 32657595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.